These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9337066)

  • 21. Parathyroid hormone effectively induces mobilization of progenitor cells without depletion of bone marrow.
    Brunner S; Zaruba MM; Huber B; David R; Vallaster M; Assmann G; Mueller-Hoecker J; Franz WM
    Exp Hematol; 2008 Sep; 36(9):1157-66. PubMed ID: 18504066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2005 May; 90(5):715-6. PubMed ID: 15921400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.
    Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM
    J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
    Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D
    Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow-derived cells into injured spinal cord and promotes functional recovery after compression-induced spinal cord injury in mice.
    Koda M; Nishio Y; Kamada T; Someya Y; Okawa A; Mori C; Yoshinaga K; Okada S; Moriya H; Yamazaki M
    Brain Res; 2007 May; 1149():223-31. PubMed ID: 17391650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
    Pelus LM; Fukuda S
    Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous peripheral blood stem cell transplantation (PBSCT) mobilized with G-CSF in AML in first complete remission. Role of intensification therapy in outcome.
    Martín C; Torres A; León A; Rubio V; Alvarez MA; Herrera C; Jean-Paul E; Correa MA; Rojas R; Campos R; Serrano J; Romero R; Román J; Guzmán JL; Flores R; Falcón M; Martínez F; Gómez P
    Bone Marrow Transplant; 1998 Feb; 21(4):375-82. PubMed ID: 9509972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor.
    Gyger M; Stuart RK; Perreault C
    Bone Marrow Transplant; 2000 Jul; 26(1):1-16. PubMed ID: 10918400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human hematopoietic progenitor in bone marrow and peripheral blood.
    Messner HA
    Stem Cells; 1998; 16 Suppl 1():93-6. PubMed ID: 11012151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Granulocyte colony-stimulating factor-mobilized autologous bone marrow stem cells promote the liver regeneration of partial liver transplant: an experiment with rats].
    Liu F; Pan XB; Chen GD; Jiang D; Cong X; Fei R; Wei L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3342-5. PubMed ID: 16409841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell function and engraftment is not affected by "in vivo purging" with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma.
    Buckstein R; Imrie K; Spaner D; Potichnyj A; Robinson JB; Nanji S; Pennel N; Reis M; Pinkerton P; Dubé I; Hewitt K; Berinstein NL
    Semin Oncol; 1999 Oct; 26(5 Suppl 14):115-22. PubMed ID: 10561026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.
    Khan AA; Parveen N; Mahaboob VS; Rajendraprasad A; Ravindraprakash HR; Venkateswarlu J; Rao SG; Narusu ML; Khaja MN; Pramila R; Habeeb A; Habibullah CM
    Transplant Proc; 2008 May; 40(4):1140-4. PubMed ID: 18555134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood progenitor cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia.
    Löwenberg B; van Putten WL; Ferrant A; Ossenkoppele G; Vellenga E; Verdonck LF; Gratwohl A; Boogaerts MA
    Stem Cells; 1997; 15 Suppl 1():177-80; discussion 181. PubMed ID: 9368339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).
    Ergene U; Cağirgan S; Pehlivan M; Yilmaz M; Tombuloğlu M
    Transfus Apher Sci; 2007 Feb; 36(1):23-9. PubMed ID: 17292672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced antileukemic activity of allogeneic peripheral blood progenitor cell transplants following donor treatment with the combination of granulocyte colony-stimulating factor (G-CSF) and stem cell factor (SCF) in a murine transplantation model.
    Hartung G; Zeis M; Glass B; Dreger P; Steinmann J; Schmitz N; Uharek L
    Bone Marrow Transplant; 2003 Jul; 32(1):49-56. PubMed ID: 12815478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial.
    Ripa RS; Haack-Sørensen M; Wang Y; Jørgensen E; Mortensen S; Bindslev L; Friis T; Kastrup J
    Circulation; 2007 Sep; 116(11 Suppl):I24-30. PubMed ID: 17846310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor.
    Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB
    Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collection of hematopoietic stem cells from patients with autoimmune diseases.
    Burt RK; Fassas A; Snowden J; van Laar JM; Kozak T; Wulffraat NM; Nash RA; Dunbar CE; Arnold R; Prentice G; Bingham S; Marmont AM; McSweeney PA
    Bone Marrow Transplant; 2001 Jul; 28(1):1-12. PubMed ID: 11498738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions.
    Huang XJ; Chang YJ; Zhao XY
    Transpl Immunol; 2007 Apr; 17(3):193-7. PubMed ID: 17331846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.